West Roxbury, MA, United States of America

Fan Zhang

This inventor holds 18 USPTO granted patents and 15 published patent applications and 3 EPO patents, primarily in Vaccine Development. Top assignees: Children's Medical Center Corporation, Affinivax, Inc.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fan Zhang. Retrieved from https://idiyas.com/inventor/fan-zhang-2empkdzl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 15)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 12)

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 61(Granted Patents)

Location History:

Chestnut Hill, MA (US) (2022)
West Roxbury, MA (US) (2016 - 2024)

Company Filing History:

13 out of 1,077

Children's Medical Center Corporation

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Multivalent Vaccines

Pneumococcal Vaccines

Immunogenic Composition

Antigen Presentation

Fusion Proteins

Biotin-Binding Protein

Mycobacterium Tuberculosis

Protein Antigens

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545710 - MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION, AND METHODS AND USES THEREOF (2026-02-10),

2. 12377140 - Multivalent pneumococcal vaccines (2025-08-05),

3. 12370247 - Multivalent pneumococcal vaccines (2025-07-29),

4. 12129283 - Pneumococcal fusion protein vaccines (2024-10-29),

5. 12090198 - Combined vaccine against mycobacterium tuberculosis (2024-09-17),

6. 12083173 - Protein antigens that provide protection against pneumococcal colonization and/or disease (2024-09-10),

7. 12036276 - Multivalent pneumococcal vaccines (2024-07-16),

8. 11981708 - Multiple antigen presenting immunogenic composition, and methods and uses thereof (2024-05-14),

9. 11976097 - Modified biotin-binding protein, fusion proteins thereof and applications (2024-05-07),

10. 11701416 - Multivalent pneumococcal vaccines (2023-07-18),

11. 11576958 - Protein antigens that provide protection against pneumococcal colonization and/or disease (2023-02-14),

12. 11560410 - Modified biotin-binding protein, fusion proteins thereof and applications (2023-01-24),

13. 11305001 - Multiple antigen presenting system (MAPS)-basedvaccine, immunogenic composition, and uses thereof (2022-04-19),

14. 11013793 - Multivalent pneumococcal vaccines (2021-05-25),

15. 10766932 - Multiple antigen presenting immunogenic composition, and methods and uses thereof (2020-09-08),

Title: The Innovations of Inventor Fan Zhang

Introduction

Fan Zhang, an accomplished inventor based in West Roxbury, MA, has made significant contributions to the field of medical technology. With a remarkable portfolio of 15 patents, his work primarily focuses on vaccines and immunological therapies that aim to combat severe infectious diseases.

Latest Patents

Among Fan Zhang's latest innovations are two noteworthy patents: the Pneumococcal fusion protein vaccines, which offer advanced technologies for the prevention and treatment of pneumococcal infections, and a combined vaccine against Mycobacterium tuberculosis. This combined vaccine presents a Multiple Antigen Presenting System (MAPS) that includes an immunogenic composition capable of inducing a robust immune response. It features a polysaccharide that can be a type of antigenic capsular polysaccharide, specifically Type 5 or Type 8, effectively linking protein or peptide antigens to elicit both humoral and cellular immune responses simultaneously.

Career Highlights

Fan Zhang has played vital roles in notable organizations, including Children’s Medical Center Corporation and Affinivax, Inc. His innovative mindset and expertise have contributed to the development of novel therapeutic solutions, positioning him as a leader in the field of immunological research.

Collaborations

Throughout his career, Fan Zhang has collaborated with esteemed colleagues, including Richard Malley and Yingjie Lu. These partnerships have been instrumental in advancing research and fostering innovative approaches to vaccine development.

Conclusion

With his impressive track record of patents and innovations, Fan Zhang is a remarkable figure in the realm of medical technology. His contributions continue to pave the way for new advancements in vaccinations and therapeutic strategies, significantly impacting public health.

Profile summary based on public USPTO records.